$AMWL

McNeice Paul Francis sold $6K of AMWL

McNeice Paul Francis (Chief Accounting Officer) sold 653 shares of American Well Corp (AMWL) at $9.33 on 2026-07-01.

Original reporting
SEC EDGAR · McNeice Paul Francis
Published Jul 1, 2026, 9:23 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 1, 2026, 9:27 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$AMWL
Neutral
medium confidence
Mentioned
$AMWL
Relevance
3/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$AMWLNeutralLow
01

Why it matters

This provides a fresh datapoint on insider behavior (CFO selling), but it does not include any new business, financial, or regulatory development.

02

Market read

Traders may note insider selling, but the transaction’s small size suggests limited tradable impact absent other catalysts.

03

What to watch

No 10b5-1 plan is indicated, but insider sales can still be scheduled outside 10b5-1; the disclosed dollar amount is very small, reducing signal-to-noise.

Relevance 3/10Novelty 3/10Timing: filed 2026-07-01 (after-hours) for an insider sale dated 2026-07-01

Background

The article is an SEC Form 4 insider transaction disclosure for American Well Corp (AMWL).

Company-level read

Ticker impact

$AMWLNeutralMedium confidence
Context

AMWL insider Form 4 shows CFO McNeice Paul Francis sold 653 shares on 2026-07-01 at $9.33, totaling ~$6.1K.

Expected impact

Limited near-term impact; any effect is likely sentiment-only and minor.

Evidence & confidence

The filing is a primary insider transaction, but the disclosed value (~$6.1K) is small relative to typical AMWL trading/market cap, and there is no accompanying operational or guidance change.

Market effects

No clear sector read-through from a small CFO sale without additional company-specific catalysts.

None.

None.

Counterpoint

The sale may be for personal liquidity/tax needs rather than a bearish signal, especially since the filing does not provide context on motives.

Key entities

  • American Well Corp

    Subject of the Form 4 insider transaction disclosure.

  • McNeice Paul Francis

    Chief Accounting Officer who sold 653 shares on 2026-07-01.

Related articles

$QTTBMedAI 8/10

Top Biotech Gainers: QTTB Sends Strong SIGNAL; AMWL And SI In Focus

Biotech gainers highlighted Q32 Bio (QTTB), up 90.7% to $21.38 after positive Phase 2 SIGNAL-AA results for bempikibart in alopecia areata, and it launched a $200M underwritten stock offering. Agenus (AGEN) rose 82.7% to $6.12 on a planned ~$85M private placement for BOT+BAL Phase 3 ROBBIN1. Other movers: ACTU, GALT, AMWL, SI.